Korsana Biosciences KRSA
NASDAQ KRSA
$33.43 +0.89 (+2.74%)
At close: Oct 22, 2026 · 4:00 PM EDT

Korsana Biosciences (KRSA) Notes Payables (2020 - 2021)

Updated

Korsana Biosciences' Notes Payables was $3.51 million in Q3 2021, unchanged from $3.51 million a year earlier and unchanged from the prior quarter.

Analysis

Korsana Biosciences (KRSA) Notes Payables (2020 - 2021) Analysis & Trends

From Q2 2020 onward, Korsana Biosciences has reported Notes Payables for 6 quarters.

  • Per Business Quant data, KRSA's Notes Payables in the three quarters before Q3 2021 was $3.51 million (Q2 2021), $3.51 million (Q1 2021) and $3.51 million (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Korsana Biosciences 15.41 Mn 954,428.44 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 3.51 Mn
Jun 30, 2021 3.51 Mn
Mar 31, 2021 3.51 Mn
Dec 31, 2020 3.51 Mn
Sep 30, 2020 3.51 Mn
Jun 30, 2020 3.51 Mn
API Access

Korsana Biosciences Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=KRSA&period=max&api_key=YOUR_API_KEY